Home

Knihovna kufru tygr houba na mytí overall immunosuppressive burden účinnost horní zlomenina

IKKα-deficient lung adenocarcinomas generate an immunosuppressive  microenvironment by overproducing Treg-inducing cytokines | PNAS
IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines | PNAS

Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-κB  signaling pathway in CD4 T cells: Molecular Therapy
Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-κB signaling pathway in CD4 T cells: Molecular Therapy

Tumor mutational burden and immunotherapy in gliomas: Trends in Cancer
Tumor mutational burden and immunotherapy in gliomas: Trends in Cancer

Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell  Levels: The Randomized, Controlled IVIST Trial | American Society of  Nephrology
Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial | American Society of Nephrology

Immunosuppressive cells in cancer: mechanisms and potential therapeutic  targets | Journal of Hematology & Oncology | Full Text
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text

Regulatory T cells in cancer immunosuppression — implications for  anticancer therapy | Nature Reviews Clinical Oncology
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy | Nature Reviews Clinical Oncology

High immunosuppressive burden in cancer patients: a major hurdle for cancer  immunotherapy | SpringerLink
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy | SpringerLink

Frontiers | Immunosuppression in Glioblastoma: Current Understanding and  Therapeutic Implications
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications

The need for minimization strategies: current problems of immunosuppression  - Bamoulid - 2015 - Transplant International - Wiley Online Library
The need for minimization strategies: current problems of immunosuppression - Bamoulid - 2015 - Transplant International - Wiley Online Library

PDF) High immunosuppressive burden in advanced hepatocellular carcinoma  patients: Can effector functions be restored?
PDF) High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?

Cancer Risk Among Immunosuppressed Populations - NCI
Cancer Risk Among Immunosuppressed Populations - NCI

Long-term use of immunosuppressive medicines and in-hospital COVID-19  outcomes: a retrospective cohort study using data from the National COVID  Cohort Collaborative - The Lancet Rheumatology
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative - The Lancet Rheumatology

Frontiers | Immunosuppression in Glioblastoma: Current Understanding and  Therapeutic Implications
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications

Systemic immunity in cancer | Nature Reviews Cancer
Systemic immunity in cancer | Nature Reviews Cancer

Mutational burden, MHC-I expression and immune infiltration as limiting  factors for in situ vaccination by TNFα and IL-12 gene electrotransfer -  ScienceDirect
Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer - ScienceDirect

Frontiers | Advances in Immune Monitoring Approaches for Sepsis-Induced  Immunosuppression
Frontiers | Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression

JCM | Free Full-Text | Post-Transplant Cyclophosphamide and  Tacrolimus—Mycophenolate Mofetil Combination Governs GVHD and  Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral  Blood Hematopoietic Cell Transplantation from HLA ...
JCM | Free Full-Text | Post-Transplant Cyclophosphamide and Tacrolimus—Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA ...

Immunosuppressive Therapy and Risk Stratification of Patients With  Myocarditis Presenting With Ventricular Arrhythmias - ScienceDirect
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias - ScienceDirect

Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote  immunosuppression in pancreatic cancer - eBioMedicine
Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancer - eBioMedicine

Frontiers | Tumor Burden and Immunotherapy: Impact on Immune Infiltration  and Therapeutic Outcomes
Frontiers | Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes

Evaluation of Changes Over Time in the Drug Burden and Medication Regimen  Complexity in ESRD Patients Before and After Renal Transplantation -  ScienceDirect
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation - ScienceDirect

Classification of primary liver cancer with immunosuppression mechanisms  and correlation with genomic alterations - eBioMedicine
Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations - eBioMedicine

Targeting immunosuppressive adenosine in cancer | Nature Reviews Cancer
Targeting immunosuppressive adenosine in cancer | Nature Reviews Cancer

Immunosuppression - an overview | ScienceDirect Topics
Immunosuppression - an overview | ScienceDirect Topics

Immunosuppressive cells in cancer: mechanisms and potential therapeutic  targets | Journal of Hematology & Oncology | Full Text
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text

Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive  microenvironment with high mutational burden in lung cancer | Journal for  ImmunoTherapy of Cancer
Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer | Journal for ImmunoTherapy of Cancer

Managing immunosuppressive therapy in potentially cured post‐kidney  transplant cancer (excluding non‐melanoma skin cancer): an overview of the  available evidence and guidance for shared decision‐making - Hellemans -  2021 - Transplant International -
Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making - Hellemans - 2021 - Transplant International -